{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:44:50Z","timestamp":1782751490654,"version":"3.54.5"},"reference-count":36,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2026,6,29]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The Roche cobas DPX assay (Roche Diagnostics) is a nucleic acid test (NAT) that detects parvovirus B19 (B19V) and hepatitis A virus (HAV) and enhances the safety of fractionated plasma protein products. Implementation of this NAT requires multiple decisions focused on test characteristics, test operationalization, and result interpretation. This study uses a decision-making process to guide the potential application of this NAT to qualify plasma for fractionation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A basic decision tree approach was used to undertake a stepwise feasibility study of the B19V\/HAV assay in a blood donor setting. Limit of detection, reproducibility, and pooling studies utilized mocked-up B19V (genotypes 1 and 2) and HAV (genotypes 1a, 2a, and 3a) specimens (BioQControl; Biologicals Quality Control B.V.), Somagen (LGC SERACARE), and anonymized COVID-19 convalescent plasma (CCP; Canadian Blood Services). The Hamilton Microlab STAR IVD Pipettor generated HAV and B19V specimen pools of 96, 24, and 6. Pools and individual specimens were tested using the DPX (Duplex HAV and Parvovirus B19 Nucleic Acid Test) on the cobas 6800\/8800 System. Data were collated using Excel (Microsoft, Seattle, WA, USA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The Roche cobas DPX reproducibly detected dilutions of B19V and HAV. Pools of 24 and 6 reproducibly detected B19V at acceptable Ct values; pools of 6 reproducibly detected HAV, although at later Ct values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Using a simple decision tree approach, this study describes how a B19V and HAV NAT could be applied for the qualification of plasma for fractionation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3138\/jammi-2025-0013","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:57:18Z","timestamp":1778522238000},"page":"155-164","source":"Crossref","is-referenced-by-count":0,"title":["A decision-making process to guide the potential application of a hepatitis A virus and parvovirus B19 nucleic acid test for qualifying plasma for fractionation"],"prefix":"10.3138","volume":"11","author":[{"given":"Leisa","family":"Bruneau","sequence":"first","affiliation":[{"name":"Canadian Blood Services, Testing, Calgary, Alberta, Canada"},{"name":"Canadian Blood Services, Surveillance and Discovery Laboratory, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"L Charlton","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Surveillance and Discovery Laboratory, Ottawa, Ontario, Canada"},{"name":"Canadian Blood Services, Microbiology, Edmonton, Alberta, Canada"},{"name":"Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bigham","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Medical Laboratory & Stem Cell Services, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Hawes","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Testing, Brampton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Tang","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Testing, Brampton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Drews","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Surveillance and Discovery Laboratory, Ottawa, Ontario, Canada"},{"name":"Canadian Blood Services, Microbiology, Edmonton, Alberta, Canada"},{"name":"Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"key":"r1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tmrv.2006.11.001","volume":"21","author":"Burnouf T","year":"2007","journal-title":"Transfus Med Rev"},{"key":"r2","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1111\/j.1537-2995.2009.02279.x","volume":"49","author":"Stramer SL","year":"2009","journal-title":"Transfusion (Paris)"},{"key":"r3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tracli.2015.11.006","volume":"23","author":"Servant-Delmas A","year":"2016","journal-title":"Transfus Clin Biol"},{"key":"r4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","volume":"15","author":"Heegaard ED","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"r5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/vox.13616","volume":"119","author":"Drews SJ","year":"2024","journal-title":"Vox Sang"},{"key":"r6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/CMR.00040-16","volume":"30","author":"Qiu J","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"r7","doi-asserted-by":"crossref","first-page":"a031880","DOI":"10.1101\/cshperspect.a031880","volume":"8","author":"Smith DB","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"r8","first-page":"1","volume-title":"Manual of clinical microbiology","author":"Drews SJ","year":"2023"},{"key":"r9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/trf.17225","volume":"63","author":"Sulkowska E","year":"2023","journal-title":"Transfusion (Paris)"},{"key":"r10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/trf.14965","volume":"59","author":"Styles CE","year":"2019","journal-title":"Transfusion (Paris)"},{"issue":"21","key":"r11","doi-asserted-by":"crossref","first-page":"2400253","DOI":"10.2807\/1560-7917.ES.2024.29.21.2400253","volume":"29","author":"Guillet M","year":"2024","journal-title":"Euro Surveill"},{"key":"r12","unstructured":"US Food and Drug Administration, Department of Health and Human Services, Center for Biologics Evaluation and Research. Nucleic acid testing to reduce the possible risk of parvovirus B19 transmission by plasma-derived products: guidance for industry. 2009. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/nucleic-acid-testing-reduce-possible-risk-parvovirus-b19-transmission-plasma-derived-products (Accessed October 7, 2025)."},{"key":"r13","first-page":"29","volume":"2017","author":"Chudy M","year":"2017","journal-title":"Pharmeur Bio Sci Notes"},{"key":"r14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12911-024-02630-z","volume":"24","author":"Gao J","year":"2024","journal-title":"BMC Med Inform Decis Mak"},{"key":"r15","unstructured":"Gao A. Decision trees. https:\/\/www.cs.toronto.edu\/\u223caxgao\/cs486686_f21\/lecture_notes\/Lecture_07_on_Decision_Trees.pdf (Accessed October 8, 2025)."},{"key":"r16","unstructured":"Roche Diagnostics cobas\u00ae DPX: Duplex test for parvovirus B19 and HAV. https:\/\/umbraco.giveblood.org\/media\/783360\/cobas-8800-dpx-assay-april-2023.pdf (Accessed October 7, 2025)."},{"key":"r17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-405914-6.00003-2","volume-title":"Methods in cell biology","author":"Jia Y","year":"2012"},{"key":"r18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2105-8-131","volume":"8","author":"Karlen Y","year":"2007","journal-title":"BMC Bioinf"},{"key":"r19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2105-7-85","volume":"7","author":"Yuan JS","year":"2006","journal-title":"BMC Bioinf"},{"key":"r20","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/j.1537-2995.2010.02591.x","volume":"50","author":"Yu MY","year":"2010","journal-title":"Transfusion (Paris)"},{"key":"r21","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2009-06-225706","volume":"114","author":"Kleinman SH","year":"2009","journal-title":"Blood"},{"key":"r22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1537-2995.2005.04387.x","volume":"45","author":"Wu CG","year":"2005","journal-title":"Transfusion (Paris)"},{"key":"r23","unstructured":"AABB. Human parvovirus B19. https:\/\/www.aabb.org\/docs\/default-source\/default-document-library\/regulatory\/eid\/human-parvovirus-b19.pdf?sfvrsn=f98853f8_3. (Accessed October 8, 2025)."},{"key":"r24","unstructured":"Bigham M, Brooks K. Fractionated blood products and associated pathogen safety. Clinical guide to transfusion. Ottawa, ON: Canadian Blood Services; 2019. p. 1\u20135."},{"key":"r25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0065-2423(05)40006-2","volume":"40","author":"Kaltenboeck B","year":"2005","journal-title":"Adv Clin Chem"},{"key":"r26","unstructured":"National Institiue for Biological Standards and Control. WHO international standard 3rd WHO international standard for parvovirus B19 for nucleic acid amplification techniques. https:\/\/nibsc.org\/documents\/ifu\/12-208.pdf. (Accessed October 8, 2025)."},{"key":"r27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/tme.12893","volume":"32","author":"Williams S","year":"2022","journal-title":"Transfus Med"},{"key":"r28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12985-025-02627-8","volume":"22","author":"Alves ADR","year":"2025","journal-title":"Virol J"},{"key":"r29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1998.38698326337.x","volume":"38","author":"Soucie JM","year":"1998","journal-title":"Transfusion (Paris)"},{"key":"r30","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/j.1537-2995.2004.04071.x","volume":"44","author":"Gowland P","year":"2004","journal-title":"Transfusion (Paris)"},{"key":"r31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1423-0410.2012.01635.x","volume":"104","author":"M\u00fcller MM","year":"2013","journal-title":"Vox Sang"},{"key":"r32","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1537-2995.2012.03705.x","volume":"52","author":"Koppelman MH","year":"2012","journal-title":"Transfusion (Paris)"},{"key":"r33","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1537-2995.2010.02995.x","volume":"51","author":"Koppelman MH","year":"2011","journal-title":"Transfusion (Paris)"},{"key":"r34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1423-0410.2011.01541.x","volume":"102","author":"Baylis SA","year":"2012","journal-title":"Vox Sang"},{"key":"r35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/vox.12403","volume":"111","author":"Pisani G","year":"2016","journal-title":"Vox Sang"},{"key":"r36","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s41564-024-01655-4","volume":"9","author":"Bradley CC","year":"2024","journal-title":"Nat Microbiol"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2025-0013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:56:11Z","timestamp":1782748571000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2025-0013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6,29]]}},"alternative-id":["10.3138\/jammi-2025-0013"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2025-0013","relation":{},"ISSN":["2371-0888"],"issn-type":[{"value":"2371-0888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}